These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19939637)
1. Pulmonary drug delivery systems for antimicrobial agents: facts and myths. Falagas ME; Michalopoulos A; Metaxas EI Int J Antimicrob Agents; 2010 Feb; 35(2):101-6. PubMed ID: 19939637 [TBL] [Abstract][Full Text] [Related]
2. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis. Falagas ME; Kasiakou SK Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582 [TBL] [Abstract][Full Text] [Related]
3. Delivery of antibiotics to the respiratory tract: an update. Traini D; Young PM Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984 [TBL] [Abstract][Full Text] [Related]
4. Inhaled antimicrobial therapy: from cystic fibrosis to the flu. O'Riordan TG Respir Care; 2000 Jul; 45(7):836-45. PubMed ID: 10926381 [TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients. Westerman EM; Heijerman HG; Frijlink HW Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406 [TBL] [Abstract][Full Text] [Related]
7. Inhaled antibiotics for gram-negative respiratory infections. Hudson R; Olson Blair B Future Med Chem; 2011 Oct; 3(13):1663-77. PubMed ID: 21942255 [TBL] [Abstract][Full Text] [Related]
8. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A; J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995 [TBL] [Abstract][Full Text] [Related]
13. [Antibiotic inhalation in cystic fibrosis. A review of the literature]. Steinkamp G Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843 [TBL] [Abstract][Full Text] [Related]
14. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Smith AW Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314 [TBL] [Abstract][Full Text] [Related]
15. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis. Esmond G; Butler M; McCormack AM J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524 [TBL] [Abstract][Full Text] [Related]
16. Aminoglycosides are useful for severe respiratory tract infections. Craig WA; Andes D Semin Respir Infect; 1997 Dec; 12(4):271-7. PubMed ID: 9436954 [TBL] [Abstract][Full Text] [Related]
17. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]